Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm

Recruiting N/A Interventional Study
Atrial Fibrillation Atrial Fibrillation, Persistent
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
125 (estimated)
Sponsor
Saint Petersburg State University, Russia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to evaluate benefits of electric cardioversion in the early and long-term postoperative period in patients after radiofrequency catheter isolation of pulmonary veins. Parameters of the left atrium will be evaluated by transthoracic echocardiography and electroanatomic mapping. Preservation of the sinus rhythm will be assessed by 24-hour electrocardiographic monitoring. Th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Informed consent signed by the patient to participate in the study. * Persistent atrial fibrillation resistant to antiarrhythmic drugs for 6 months or more * The size of the left atrium is less than 55 mm, volume is less than 130 ml, volume index (LP) is less than 55 ml/m2 Ex…
Contacts

Anton A Sheremet, MD

+79313084398

sheremet.dr@yandex.ru

CONTACT

Aleksei A Filippov, MD, PhD

+79819553639

aleksei.filippov.chb@gmail.com

CONTACT